ShareValue scores for 600594.SHG: Valuation 64, Quality 32, Growth 34, Health 39.
600594.SHGSSE
Guizhou Yibai Pharmaceutical Co Ltd
CN¥3.75
(+6.23%)
600594.SHGSSE
Guizhou Yibai Pharmaceutical Co Ltd
Verdicts
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
Rating
Trap Risk
Return
Company Details
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inflammatory, analgesic, cancer, orthopedics, digestion, andrology, and urology. The company also engages in investment in the cultivation and breeding projects of medicinal materials; and agricultural products sale, as well as provides market information consulting services for medicinal materials. In addition, it is involved in the research and development, and information consulting services for health food. The company was founded in 1995 and is based in Guiyang, China.